CHRIS AMOS to Lung
This is a "connection" page, showing publications CHRIS AMOS has written about Lung.
Connection Strength
1.100
-
Common and distinct patterns of acquired uniparental disomy and homozygous deletions between lung squamous cell carcinomas and lung adenocarcinoma. Neoplasia. 2023 11; 45:100932.
Score: 0.120
-
Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. Hum Mol Genet. 2023 09 05; 32(18):2842-2855.
Score: 0.119
-
Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer. J Thorac Oncol. 2023 09; 18(9):1184-1198.
Score: 0.116
-
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020 06 15; 201(12):1557-1559.
Score: 0.095
-
Immune-mediated genetic pathways resulting in pulmonary function impairment increase lung cancer susceptibility. Nat Commun. 2020 01 07; 11(1):27.
Score: 0.092
-
Prediction of the gene expression in normal lung tissue by the gene expression in blood. BMC Med Genomics. 2015 Nov 17; 8:77.
Score: 0.069
-
Fine-mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 regions identifies functional and histology-specific lung cancer susceptibility loci in African-Americans. Cancer Epidemiol Biomarkers Prev. 2013 Feb; 22(2):251-60.
Score: 0.057
-
Genetic determinants for promoter hypermethylation in the lungs of smokers: a candidate gene-based study. Cancer Res. 2012 Feb 01; 72(3):707-15.
Score: 0.053
-
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model. Cancer. 2024 03 01; 130(5):770-780.
Score: 0.030
-
Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. J Natl Cancer Inst. 2023 09 07; 115(9):1050-1059.
Score: 0.030
-
Circulating proteome for pulmonary nodule malignancy. J Natl Cancer Inst. 2023 09 07; 115(9):1060-1070.
Score: 0.030
-
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. Ann Epidemiol. 2023 01; 77:1-12.
Score: 0.028
-
Functional studies of lung cancer GWAS beyond association. Hum Mol Genet. 2022 10 20; 31(R1):R22-R36.
Score: 0.028
-
Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. Hum Mol Genet. 2022 08 23; 31(16):2831-2843.
Score: 0.028
-
Genetic variants associated mRNA stability in lung. BMC Genomics. 2022 Mar 11; 23(1):196.
Score: 0.027
-
Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer. J Natl Cancer Inst. 2022 01 11; 114(1):87-96.
Score: 0.027
-
SARS-CoV-2 Impairs Dendritic Cells and Regulates DC-SIGN Gene Expression in Tissues. Int J Mol Sci. 2021 Aug 26; 22(17).
Score: 0.026
-
Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study. J Thorac Oncol. 2021 07; 16(7):1127-1135.
Score: 0.025
-
Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 2021 06; 16(6):968-979.
Score: 0.025
-
Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 2021 03 15; 81(6):1607-1615.
Score: 0.025
-
Genome-wide association study of familial lung cancer. Carcinogenesis. 2018 09 21; 39(9):1135-1140.
Score: 0.021
-
Susceptibility loci of CNOT6 in the general mRNA degradation pathway and lung cancer risk-A re-analysis of eight GWASs. Mol Carcinog. 2017 04; 56(4):1227-1238.
Score: 0.019
-
Fine mapping of chromosome 6q23-25 region in familial lung cancer families reveals RGS17 as a likely candidate gene. Clin Cancer Res. 2009 Apr 15; 15(8):2666-74.
Score: 0.011